Smart Immune is a clinical-stage biotechnology company developing ProTcell™a thymus-empowered cell therapy platform to fully and rapidly re-arm the immune system, enabling next generation allogeneic T-cell therapies for all. Interview with Karine Rossignol, CEO and co-founder

Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders. Interview with Carole Desseaux, Chief Clinical Officer

ImCheck Therapeutics is designing and developing novel immunotherapeutics that target members of the butyrophilin (BTN) and BTN-like (BTNL) superfamily of checkpoint molecules with an initial focus on gamma delta (γ9δ2) T cells. Interview with Paul Frohna, Chief Medical Officer